Cargando…

Fibrotic response in fibroblasts from congenital disorders of glycosylation

Congenital disorders of glycosylation (CDG) are characterized by a generalized underglycosylation of proteins. CDG is associated with multiple symptoms such as psychomotor retardation, hypotonia, hormonal disturbances, liver fibrosis and coagulopathies. The molecular basis of these symptoms is poorl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lecca, M Rita, Maag, Charlotte, Berger, Eric G, Hennet, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373368/ https://www.ncbi.nlm.nih.gov/pubmed/21029365 http://dx.doi.org/10.1111/j.1582-4934.2010.01187.x

Ejemplares similares

Glycosylation site occupancy in health, congenital disorder of glycosylation and fatty liver disease
por: Hülsmeier, Andreas J., et al.
Publicado: (2016)

Glycosylation-Dependent Induction of Programmed Cell Death in Murine Adenocarcinoma Cells
por: Parshenkov, Aleksei, et al.
Publicado: (2022)

Congenital disorders of glycosylation (CDG): state of the art in 2022
por: Francisco, Rita, et al.
Publicado: (2023)

Insights into complexity of congenital disorders of glycosylation
por: Goreta, Sandra Supraha, et al.
Publicado: (2012)

Treatment Options in Congenital Disorders of Glycosylation
por: Park, Julien H., et al.
Publicado: (2021)

Hemostatic defects in congenital disorders of glycosylation
por: Pascreau, Tiffany, et al.
Publicado: (2023)

Congenital Disorders of Glycosylation from a Neurological Perspective
por: Paprocka, Justyna, et al.
Publicado: (2021)

Nutritional Therapies in Congenital Disorders of Glycosylation (CDG)
por: Witters, Peter, et al.
Publicado: (2017)

Clinical glycomics for the diagnosis of congenital disorders of glycosylation
por: Abu Bakar, Nurulamin, et al.
Publicado: (2018)

Liver Involvement in Congenital Disorders of Glycosylation and Deglycosylation
por: Lipiński, Patryk, et al.
Publicado: (2021)

Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)
por: Brasil, Sandra, et al.
Publicado: (2022)

Dissecting Total Plasma and Protein-Specific Glycosylation Profiles in Congenital Disorders of Glycosylation
por: Hipgrave Ederveen, Agnes L., et al.
Publicado: (2020)

Fibroblasts are not just fibroblasts: clear differences between dermal and pulmonary fibroblasts’ response to fibrotic growth factors
por: Madsen, Sofie Falkenløve, et al.
Publicado: (2023)

Stakeholders’ views on drug development: the congenital disorders of glycosylation community perspective
por: Monticelli, Maria, et al.
Publicado: (2022)

Transferrin mutations at the glycosylation site complicate diagnosis of congenital disorders of glycosylation type I
por: Guillard, Mailys, et al.
Publicado: (2011)

Fibrotic Scar in CNS Injuries: From the Cellular Origins of Fibroblasts to the Molecular Processes of Fibrotic Scar Formation
por: Ayazi, Maryam, et al.
Publicado: (2022)

Macular Hypoplasia in Congenital Disorder of Glycosylation Type Ia
por: Wang, Bob Z., et al.
Publicado: (2012)

Clinical diagnostics and therapy monitoring in the congenital disorders of glycosylation
por: Van Scherpenzeel, Monique, et al.
Publicado: (2016)

Congenital Disorders of Glycosylation: What Clinicians Need to Know?
por: Lipiński, Patryk, et al.
Publicado: (2021)

New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach
por: Francisco, Rita, et al.
Publicado: (2020)

Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation
por: Di Patria, Laura, et al.
Publicado: (2022)

Rac Inhibition Reverses the Phenotype of Fibrotic Fibroblasts
por: Shi-wen, Xu, et al.
Publicado: (2009)

Dissecting Fibroblast Heterogeneity in Health and Fibrotic Disease
por: Shaw, Tanya J, et al.
Publicado: (2020)

Neural and Synaptic Defects in slytherin, a Zebrafish Model for Human Congenital Disorders of Glycosylation
por: Song, Yuanquan, et al.
Publicado: (2010)

CNS fibroblasts form a fibrotic scar in response to immune cell infiltration
por: Dorrier, Cayce E., et al.
Publicado: (2021)

Abnormal expression of lysosomal glycoproteins in patients with congenital disorders of glycosylation
por: Sabry, Sahar, et al.
Publicado: (2023)

Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts
por: Huang, S K, et al.
Publicado: (2013)

LR8 expression in fibroblasts of healthy and fibrotic human tissues
por: Etikala, Anusha, et al.
Publicado: (2017)

Defining the Cardiac Fibroblast Secretome in a Fibrotic Microenvironment
por: Ceccato, Tova L., et al.
Publicado: (2020)

Slow Interstitial Fluid Flow Activates TGF-β Signaling and Drives Fibrotic Responses in Human Tenon Fibroblasts
por: Wiedenmann, Cornelius Jakob, et al.
Publicado: (2023)

Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation
por: Heywood, Wendy E., et al.
Publicado: (2016)

Modeling Congenital Disorders of N-Linked Glycoprotein Glycosylation in Drosophila melanogaster
por: Frappaolo, Anna, et al.
Publicado: (2018)

Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation
por: Lao, Jessica P., et al.
Publicado: (2018)

Sugary Logistics Gone Wrong: Membrane Trafficking and Congenital Disorders of Glycosylation
por: Linders, Peter T. A., et al.
Publicado: (2020)

Congenital disorders of glycosylation: Prevalence, incidence and mutational spectrum in the Polish population
por: Lipiński, Patryk, et al.
Publicado: (2021)

GMPPB-congenital disorders of glycosylation associate with decreased enzymatic activity of GMPPB
por: Liu, Zhe, et al.
Publicado: (2021)

Perinatal manifestations of congenital disorders of glycosylation—A clue to early diagnosis
por: Greczan, Milena, et al.
Publicado: (2022)

Congenital disorders of glycosylation: narration of a story through its patents
por: Monticelli, Maria, et al.
Publicado: (2023)

Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1
por: Jin, Jin, et al.
Publicado: (2019)

Cardiac Fibroblasts Mediate a Sexually Dimorphic Fibrotic Response to β‐Adrenergic Stimulation
por: Peter, Angela K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9vuonfo9kvc32v1dmhadaops8s